ReviewLysophospholipids in the nervous system
Introduction
Lysophospholipids are small lipid molecules that have been shown, in recent years, to have a range of important effects on many different organ systems. The best studied examples of lysophospholipids are lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), which are part of a host of related molecules that are defined by a 3-carbon backbone, glycerol or sphingoid in nature, to which an acyl chain having variable length and saturation is attached. A major focus in recent years has been the action of extracellular lysophospholipids through their cognate G protein coupled receptors (GPCRs): there are nine lysophospholipids receptors, 4 for LPA (LPA1–4) and 5 for S1P (S1P1–5), with a number of putative lysophospholipid GPCRs existing in the literature. Recent reviews have covered many facets of this rapidly growing field in detail [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17] and no attempt will be made to review this extensive literature. The purpose of this opinion piece is to stimulate discussion and increase awareness of areas relevant to Neuroscience, towards achieving an understanding of both the basic neurobiology of lysophospholipid signaling, and a framework for therapeutically useful strategies involving activated pathways.
Section snippets
Discussion
An essential distinction that must be made in assessing effects produced by lysophospholipids is whether their effects involve surface receptors – GPCRs – or non-GPCR mechanisms that could utilize different pathways, such as seen with S1P intracellular functions in Arabidopsis [18]. The necessity for this distinction, particularly in the nervous system where there exists enormous complexity of cellular interactions, is differentiating true signaling properties of lysophospholipids from
Acknowledgement
This work was supported by the NIMH.
References (42)
Sphingosine 1-phosphate receptors
Prostaglandins
(2001)- et al.
Sphingosine 1-phosphate: synthesis and release
Prostaglandins
(2001) - et al.
Signaling of sphingosine-1-phosphate via the s1p/edg-family of g-protein-coupled receptors
Biochim Biophys Acta
(2002) - et al.
Sphingosylphosphorylcholine-biological functions and mechanisms of action
Biochim Biophys Acta
(2002) Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
Biochim Biophys Acta
(2002)- et al.
Pathways of transduction engaged by sphingosine 1-phosphate through g protein-coupled receptors
Biochim Biophys Acta
(2002) - et al.
Sphingosine 1-phosphate, a key cell signaling molecule
J Biol Chem
(2002) - et al.
Lysophosphatidic acid as an autocrine and paracrine mediator
Biochim Biophys Acta
(2002) Signaling and biological actions of sphingosine 1-phosphate
Pharmacol Res
(2003)- et al.
Lysophospholipid g protein-coupled receptors
J Biol Chem
(2004)
Identification of p2y9/gpr23 as a novel g protein-coupled receptor for lysophosphatidic acid, structurally distant from the edg family
J Biol Chem
In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice
Biochim Biophys Acta
Lpa1 receptor-deficient mice have phenotypic changes observed in psychiatric disease
Mol Cell Neurosci
The lpa receptors
Prostaglandins Other Lipid Mediat
Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase c-dependent pathway
J Biol Chem
The immune modulator fty720 targets sphingosine 1-phosphate receptors
J Biol Chem
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in sjl mice
J Neuroimmunol
Sphingosine 1-phosphate pathway therapeutics: A lipid ligand-receptor paradigm
Curr Opin Chem Biol
Lysophospholipid receptors
Annu Rev Pharmacol Toxicol
Lysophospholipids-receptor revelations
Science
The edg family g protein-coupled receptors for lysophospholipids: their signaling properties and biological activities
J Biochem (Tokyo)
Cited by (46)
Gintonin influences the morphology and motility of adult brain neurons via LPA receptors
2021, Journal of Ginseng ResearchGintonin, a ginseng-derived exogenous lysophosphatidic acid receptor ligand, enhances blood-brain barrier permeability and brain delivery
2018, International Journal of Biological MacromoleculesCitation Excerpt :Moreover, LPA administered intravenously can transiently increase the permeability of the BBB [20]. Thus, LPA decreases the resistance of the BBB by increasing the paracellular permeability through Rho-associated kinase (ROCK) activation, and allows large molecules to enter the brain [18,20,21]. Although previous studies have reported that LPA transiently enhances delivery of large molecules to the brain, it was unclear how LPA binds to and induces morphological changes of HBMECs.
Lysophospholipids: Advances in Synthesis and Biological Significance
2015, Polar Lipids: Biology, Chemistry, and TechnologyNovel evidence for enhanced stem cell trafficking in antipsychotic-naïve subjects during their first psychotic episode
2014, Journal of Psychiatric ResearchCitation Excerpt :Moreover, S1P mediates the migration of neural progenitor cells toward sites of spinal injury (Hurst et al., 2008; Kimura et al., 2007). Chun (2005) suggested that S1P has an important, but still unknown, role in oligodendrocyte differentiation, development, and myelination in vivo. However, the results of the examination of SDF-1 plasma level in the first episode of psychosis were inconclusive (Fernandez-Egea et al., 2009; Hill et al., 2013).
Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations
2013, Chemistry and Physics of LipidsCitation Excerpt :Along with the lysophosphatidic acid (LPA) receptors, the S1P receptors were originally named the endothelial differentiation gene (EDG) family of Class A GPCRs. There are five known S1P receptor subtypes, S1P 1–5, that are expressed on a wide range of cell types, including neural cells and lymphocytes (Chun, 1999, 2005; Chun et al., 1999, 2000; Sanchez and Hla, 2004; Zhang et al., 1999). S1P1–3 receptors are found widely distributed in the CNS, immune and cardiovascular systems.